Lightbridge (LTBR) 10-Q 19 Aug 15 2015 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	6 Months Ended
	Jun. 30, 2015	Aug. 03, 2015
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Jun. 30, 2015
Trading Symbol	ltbr
Entity Registrant Name	LIGHTBRIDGE Corp
Entity Central Index Key	1,084,554
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		18,082,874
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well Known Seasoned Issuer	No
Document Fiscal Year Focus	2,015
Document Fiscal Period Focus	Q2

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Jun. 30, 2015	Dec. 31, 2014
Current Assets
Cash and cash equivalents	$ 2,371,266	$ 4,220,225
Restricted cash	325,505	325,181
Accounts receivable - project revenue and reimbursable project costs	247,144	469,086
Prepaid expenses and other current assets	203,795	205,184
Total Current Assets	3,147,710	5,219,676
Property Plant and Equipment -net	0	0
Other Assets
Patent costs	883,775	833,560
Total Assets	4,031,485	6,053,236
Current Liabilities
Accounts payable and accrued liabilities	452,571	653,668
Total Current Liabilities	$ 452,571	$ 653,668
Commitments and contingencies
Stockholders' Equity
Preferred stock, $0.001 par value, 50,000,000 authorized shares, no shares issued and outstanding	$ 0	$ 0
Common stock, $0.001 par value, 500,000,000 authorized, 18,082,874 shares outstanding at June 30, 2015 and December 31, 2014	18,083	18,083
Additional paid-in capital - stock and stock equivalents	82,016,278	81,276,339
Accumulated Deficit	(78,455,447)	(75,894,854)
Total Stockholders' Equity	3,578,914	5,399,568
Total Liabilities and Stockholders' Equity	$ 4,031,485	$ 6,053,236

Condensed Consolidated Balance3

Condensed Consolidated Balance Sheets (PARENTHETICAL) - $ / shares	Jun. 30, 2015	Dec. 31, 2014
Preferred Stock, Par Value Per Share	$ 0.001	$ 0.001
Preferred Stock, Shares Authorized	50,000,000	50,000,000
Preferred Stock, Shares Issued
Preferred Stock, Shares Outstanding
Common Stock, Par Value Per Share	$ 0.001	$ 0.001
Common Stock, Shares Authorized	500,000,000	500,000,000
Common Stock, Shares, Issued	18,082,874	18,082,874
Common Stock, Shares, Outstanding	18,082,874	18,082,874

Unaudited Condensed Consolidate

Unaudited Condensed Consolidated Statements of Operations - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Revenue:
Consulting Revenue	$ 298,162	$ 349,131	$ 422,057	$ 603,238
Cost of Consulting Services Provided	275,662	230,974	333,054	355,986
Gross Margin	22,500	118,157	89,003	247,252
Operating Expenses
General and administrative	1,108,807	1,149,420	2,039,100	2,280,839
Research and development expenses	394,715	624,448	607,545	1,056,434
Total Operating Expenses	1,503,522	1,773,868	2,646,645	3,337,273
Operating Loss	(1,481,022)	(1,655,711)	(2,557,642)	(3,090,021)
Other Income and (Expenses)
Investment income	163	603	323	991
Other income (expenses)	(762)	0	(3,274)	0
Total Other Income and (Expenses)	(599)	603	(2,951)	991
Net loss before income taxes	(1,481,621)	(1,655,108)	(2,560,593)	(3,089,030)
Income taxes	0	0	0	0
Net loss	$ (1,481,621)	$ (1,655,108)	$ (2,560,593)	$ (3,089,030)
Net Loss Per Common Share, Basic and Diluted	$ (0.08)	$ (0.11)	$ (0.14)	$ (0.21)
Weighted Average Number of Shares Outstanding	18,082,874	15,067,885	18,082,874	15,063,052

Unaudited Condensed Consolidat5

Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)	6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014
Cash Flows from Operating Activities:
Net Loss	$ (2,560,593)	$ (3,089,030)
Adjustments to reconcile net loss from operations to net cash used in operating activities:
Stock-based compensation	782,036	125,297
Loss on marketable securities	0	(792)
Changes in non-cash operating working capital items:
Accounts receivable - fees and reimbursable project costs	221,942	17,685
Prepaid expenses and other assets	1,389	(50,203)
Accounts payable and accrued liabilities	(201,097)	378,220
Net Cash Used In Operating Activities	(1,756,323)	(2,618,823)
Cash Flows from Investing Activities:
Payments for Patent costs	(50,215)	(65,546)
Net Cash Used In Investing Activities	(50,215)	(65,546)
Cash Flows from Financing Activities:
Payments for Stock offering costs	(42,097)	0
Restricted cash	(324)	(554)
Net Cash Used In Financing Activities	(42,421)	(554)
Net Decrease In Cash and Cash Equivalents	(1,848,959)	(2,684,923)
Cash and Cash Equivalents, Beginning of Period	4,220,225	3,672,877
Cash and Cash Equivalents, End of Period	2,371,266	987,954
Cash paid during the year:
Interest	0	0
Income taxes	$ 0	$ 0

Basis of Presentation, Summary

Basis of Presentation, Summary of Significant Accounting Policies and Nature of Operations	6 Months Ended
	Jun. 30, 2015
Basis of Presentation, Summary of Significant Accounting Policies and Nature of Operations [Text Block]	Note 1. Basis of Presentation, Summary of Significant Accounting Policies and Nature of Operations Basis of presentation The accompanying unaudited condensed consolidated financial statements of Lightbridge Corporation and its subsidiaries have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission, or the SEC, including the instructions to Form 10-Q and Regulation S-X. Certain information and note disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States of America have been condensed or omitted from these statements pursuant to such rules and regulations and, accordingly, they do not include all the information and notes necessary for comprehensive consolidated financial statements and should be read in conjunction with our audited consolidated financial statements for the year ended December 31, 2014, included in our Annual Report on Form 10-K for the year ended December 31, 2014. In the opinion of the management of the Company, all adjustments, which are of a normal recurring nature, necessary for a fair statement of the results for the periods presented, have been made. Results for the interim periods presented are not necessarily indicative of the results that might be expected for the entire fiscal year. When used in these notes, the terms "Company,” "we,” "us" or "our" mean Lightbridge Corporation and all entities included in our consolidated financial statements. We were formed on October 6, 2006, when Thorium Power, Ltd. merged with Thorium Power, Inc., (“TPI”), which had been formed in the State of Delaware on January 8, 1992. On September 29, 2009, we changed our name from Thorium Power, Ltd. to Lightbridge Corporation (“Lightbridge” or the “Company”). We are engaged in two operating business segments: our Technology Business Segment and our Consulting Business Segment (see Note 8-Business Segment Results). Technology Business Segment Our primary business segment, based on future revenue potential, is to develop innovative, proprietary nuclear fuel designs which we expect will significantly enhance the nuclear power industry’s economics and increase power output. We are currently focusing our development efforts primarily on the metallic fuel with a power uprate of up to 10% and a 24 -month operating cycle in existing Westinghouse-type four-loop pressurized water reactors. Those reactors represent the largest segment of our global target market. Our metallic fuel could also be adapted for use in other types of water-cooled commercial power reactors, such as boiling water reactors, CANDU heavy water reactors, as well as water-cooled small modular reactors. On October 20, 2014, we announced the signing of an initial cooperation agreement with Canadian Nuclear Laboratories (“CNL”), formerly known as Atomic Energy of Canada Limited-Chalk River Laboratories, for fabrication of Lightbridge's patented next generation metallic nuclear fuel samples. Our plan is to work with CNL on fabrication of our fuel samples at their Chalk River facilities in Canada, with full irradiation of the fabricated fuel samples to be performed separately in a pressurized water loop of the Halden research reactor located in Halden, Norway. On July 8, 2015 we entered into a service agreement with the Institute for Energy Technology (“IFE”) of Norway for irradiation testing of Lightbridge advanced metallic nuclear fuel samples under prototypic commercial reactor operating conditions in IFE’s Halden research reactor, southeast of Oslo. Consulting Business Segment Our business model expanded with the establishment of a consulting business segment in 2007, through which we provide consulting and strategic advisory services to companies and governments planning to create or expand electricity generation capabilities using nuclear power plants. On August 1, 2008, we signed separate consulting services agreements with two government entities: Emirates Nuclear Energy Corporation (“ENEC”) formed by Abu Dhabi, one of the member Emirates of the United Arab Emirates (“UAE”), and the Federal Authority for Nuclear Regulation (“FANR”) formed by the government of the UAE. Under these two original agreements, we have provided consulting and strategic advisory services over a contract term of five years starting from June 23, 2008. The ENEC contract has been extended through 2015. The FANR contract has been extended to December 31, 2016. These contracts can each continue to be extended upon agreement by both parties. On August 11, 2014, we were selected to provide quality assurance, safety and construction inspection services in support of the in-house inspection team of FANR. As a team with Lloyd’s Register, this work is in addition to our ongoing support of FANR’s activities. During the fourth quarter of 2014, we signed a contract with ENEC to provide management consulting services to their Seoul Korea office, on a time and material basis. Accounting Policies and Pronouncements Basis of Consolidation These consolidated financial statements include the accounts of Lightbridge, a Nevada corporation, and our wholly-owned subsidiaries, TPI, a Delaware corporation, Lightbridge International Holding LLC, a Delaware limited liability company, and our foreign branch offices. All significant intercompany transactions and balances have been eliminated in consolidation. We registered a branch office in the United Kingdom in 2008 called Lightbridge Advisors Limited (inactive) and we also established a branch office in Moscow, Russia, in July 2009, both of which are wholly owned by Lightbridge International Holding LLC at December 31, 2014. These branch offices will be closed in 2015. Translation gains and losses for the three and six months ended June 30, 2015 and 2014 were not significant. Foreign branches are winding down as of June 30, 2015. Certain Risks, Uncertainties and Concentrations We are an early stage company and will likely need additional funding by way of strategic alliances, further offerings of equity securities, an offering of debt securities, or a financing through a bank in order to support the remaining research and development activities required to further enhance and complete the development of our fuel products to a commercial stage. Currently, we are working on consulting revenue opportunities with the overall goal of increasing our profitability and cash flow. We participate in a government-regulated industry. Our operating results are affected by a wide variety of factors including decreases in the use or public favor of nuclear power, the ability of our technology to safeguard the production of nuclear power and our ability to safeguard our patents and intellectual property from competitors. Due to these factors, we may experience substantial period-to-period fluctuations in our future operating results. Potentially, a loss of a key officer, key management, and other personnel could impair our ability to successfully execute our business strategy, particularly when these individuals have acquired specialized knowledge and skills with respect to nuclear power and our operations. Our future operations and earnings currently depend on the results of the Company’s operations outside the United States. There can be no assurance that the Company will be able to successfully continue to conduct such operations, and a failure to do so would have a material adverse effect on the Company’s research and development activities, financial position, results of operations, and cash flows. Also, the success of the Company’s operations will be subject to other numerous contingencies, some of which are beyond management’s control. These contingencies include general and regional economic conditions, competition, changes in regulations, changes in accounting and taxation standards, inability to achieve overall long-term goals, future impairment charges and global or regional catastrophic events. Because the Company is dependent on its international operations for almost all its revenue, the Company may be subject to various additional political, economic, and other uncertainties. Accounts receivable are typically unsecured and are primarily derived from revenues earned from customers located in the Middle East. We perform ongoing evaluations to determine customer credit and we limit the amount of credit we extend, but generally we do not require collateral from our customers. We maintain reserves for estimated credit losses if necessary, however, no reserve has been set up at June 30, 2015 and 2014, as we have not incurred any credit losses from our customers to date. Approximately 60% and 80% of the total revenues reported for the three months ended June 30, 2015 and 2014, respectively, were from the ENEC and FANR contracts. The ENEC and FANR contracts were approximately 60% and substantially all of our consulting revenues for the six months ended June 30, 2015 and 2014, respectively. Contracts with one other customer constituted approximately 40% and 20% of the total revenues reported for the three months ended June 30, 2015 and 2014, respectively, and approximately 40% and 20% of the total revenues reported for the six months ended June 30, 2015 and 2014, respectively. Revenue Recognition Consulting Business Segment At the present time, we derive all of our revenue from our consulting business segment on a time and expense basis as provided, by offering consulting services to governments outside the United States planning to create or expand electricity generation capabilities using nuclear power plants. Our fee structure for each client engagement is dependent on a number of variables, including the size of the client, the complexity, the level of the opportunity for us to improve the client’s electrical generation capabilities using nuclear power plants, and other factors. The accounting policy we use to recognize revenue depends on the terms and conditions of the specific contract. Revenues from the Executive Affairs Authority (“EAA”) of Abu Dhabi, one of the member Emirates of the UAE, and the related entities, ENEC and FANR, are billed on both a time and expense basis and on a fixed contract basis with revenue recognized based on the acceptance of defined contract deliverables. Certain customer arrangements require evaluation of the criteria outlined in the accounting standards for reporting revenue “ Gross as a Principal Versus Net as an Agent ” in determining whether it is appropriate to record the gross amount of revenue and related costs, or the net amount earned as agent fees. Generally, when we are primarily obligated in a transaction, revenue is recorded on a gross basis. Other factors that we consider in determining whether to recognize revenue on a gross versus net basis include our assumption of credit risk, latitude in establishing prices, our determination of service specifications, and our involvement in the provision of services. We have determined, based on the credit risk that we bear for collecting consulting fees, travel costs, and other reimbursable costs from our customers, that in 2015 and 2014 we acted as a principal, and therefore we are recognizing as revenue all travel costs and other reimbursable costs billed to our customers. Cost of consulting services includes labor, travel expenses, stock-based compensation and other related consulting costs. Technology Business Segment Once our nuclear fuel designs have advanced to a commercially usable stage by a fuel fabricator and/or nuclear plant owner/operator, we will seek to license our technology to them or to major government contractors working for the applicable government. We expect that our revenue from these license fees will be recognized on a straight-line basis over the expected period of the related license term. Stock-Based Compensation The stock-based compensation expense incurred by Lightbridge for employees and directors in connection with its stock option plan is based on the employee model of ASC 718, and the fair market value of the options is measured at the grant date. Under ASC 718 employee is defined as, “An individual over whom the grantor of a share-based compensation award exercises or has the right to exercise sufficient control to establish an employer-employee relationship based on common law as illustrated in case law and currently under U.S. Tax Regulations.” Our advisory board members and consultants do not meet the employer-employee relationship as defined by the IRS and therefore are accounted for under ASC 505-50. ASC 505-50-30-11 (previously EITF 96-18) further provides that an issuer shall measure the fair value of the equity instruments in these transactions using the stock price and other measurement assumptions as of the earlier of the following dates, referred to as the measurement date: i. The date at which a commitment for performance by the counterparty to earn the equity instruments is reached (a performance commitment); and ii. The date at which the counterparty’s performance is complete. We have elected to use the Black-Scholes pricing model to determine the fair value of stock options on the measurement date of the grant. Restricted stock units are measured based on the fair market values of the underlying stock on the measurement date of the grant. Shares that are issued to officers on the exercise dates of their stock options may be issued net of the statutory withholding requirements to be paid by us on behalf of our employees. As a result, the actual number of shares issued will be fewer than the actual number of shares exercised under the stock option. We recognize stock-based compensation using the straight-line method over the requisite service period. Cash and Cash Equivalents and Restricted Cash We invest our excess cash in money market mutual funds. We classify all highly liquid investments with stated maturities of three months or less from date of purchase as cash equivalents and all highly liquid investments with stated maturities of greater than three months as marketable securities. We hold cash balances in excess of the federally insured limits of $250,000 with one prominent financial institution. We deem this credit risk not to be significant as our cash is held by a major prominent financial institution. Total cash and cash equivalents held in checking accounts and a money market core cash account, as reported on the accompanying consolidated condensed balance sheets, totaled approximately $2.4 million and $4.2 million at June 30, 2015 and December 31, 2014, respectively. Restricted cash represents cash being held by the same prominent financial institution that is being used as collateral for our corporate credit cards and future letters of credit that we may issue to some of our foreign customers. The total balance of our restricted cash at June 30, 2015 and December 31, 2014, was approximately $0.3 million. Trade Accounts Receivable We record accounts receivable at the invoiced amount and we do not charge interest. We review the accounts receivable by amounts due from customers which are past due, to identify specific customers with known disputes or collectability issues. In determining the amount of the reserve, we make judgments about the creditworthiness of significant customers based on ongoing credit evaluations. We will also maintain a sales allowance to reserve for potential credits issued to customers. We will determine the amount of the reserve based on historical credits issued. There was no provision for doubtful accounts recorded at June 30, 2015 and December 31, 2014, as we have not experienced any bad debts from any of our customers. Foreign Currency The functional currency of our international branches is the local currency. We translate the financial statements of these branches to U.S. dollars using period-end rates of exchange for assets and liabilities, and average rates of exchange for revenues, costs, and expenses. The translation gains/losses for our branch office in Russia were not significant for the three and six months ended June 30, 2015 and 2014. Patents and Legal Costs Patents are stated on the accompanying condensed consolidated balance sheets at cost. The costs of the patents, once placed in service, will be amortized on a straight-line basis over their estimated useful lives or the remaining legal lives of the patents, whichever is shorter. The amortization periods for our patents can range between 17 and 20 years if placed into service at the beginning of their legal lives. Our patents have not been placed in service for the three and six months ended June 30, 2015 and 2014. Legal costs are expensed as incurred except for legal costs to file for patent protection, which are capitalized and reported as patents on the accompanying condensed consolidated balance sheets. Impairment of long-lived assets Long-lived assets of the Company are reviewed for impairment whenever events or circumstances indicate that the carrying amount of assets may not be recoverable. The Company recognizes an impairment loss when the sum of expected undiscounted future cash flows is less than the carrying amount of the asset. The amount of impairment is measured as the difference between the asset’s estimated fair value and its book value. The Company did not consider it necessary to record any impairment charges for the three and six months ended June 30, 2015 and 2014. Research, Development and Related Expenses These costs from our Technology business segment are charged to operations in the period incurred and are shown on a separate line on the accompanying condensed consolidated statements of operations. Segment Reporting We use the “management approach” in determining reportable operating segments. The management approach considers the internal organization and reporting used by our chief decision makers for making operating decisions and assessing performance, as the source for determining our reportable segments. We have determined that we have two operating segments as defined by the FASB accounting pronouncement, “ Disclosures about Segments of an Enterprise and Related Information Recent Accounting Pronouncements Revenue Recognition In May 2014, the FASB issued guidance on revenue from contracts with customers that will supersede most current revenue recognition guidance, including industry-specific guidance. The underlying principle is that an entity will recognize revenue to depict the transfer of goods or services to customers at an amount that the entity expects to be entitled to in exchange for those goods or services. The guidance provides a five-step analysis of transactions to determine when and how revenue is recognized. Other major provisions include capitalization of certain contract costs, consideration of time value of money in the transaction price, and allowing estimates of variable consideration to be recognized before contingencies are resolved in certain circumstances. The guidance also requires enhanced disclosures regarding the nature, amount, timing and uncertainty of revenue and cash flows arising from an entity’s contracts with customers. The guidance is effective for the interim and annual periods beginning on or after December 15, 2017, (early adoption is not permitted). The guidance permits the use of either a retrospective or cumulative effect transition method. Going Concern In August 2014, FASB issued guidance that requires management to perform interim and annual assessments of an entity’s ability to continue as a going concern within one year of the date the financial statements are issued. An entity must provide certain disclosures if conditions or events raise substantial doubt about the entity’s ability to continue as a going concern. The updated accounting guidance will be effective for the Company on January 1, 2017, and early adoption is permitted. The Company will evaluate the going concern considerations in this guidance upon adoption. The Company does not expect the adoption of any recent accounting pronouncements to have a material impact on its financial statements.

Net Loss Per Share

Net Loss Per Share	6 Months Ended
	Jun. 30, 2015
Net Loss Per Share [Text Block]	Note 2. Net Loss Per Share Basic net loss per share is computed using the weighted-average number of common shares outstanding during the period except that it does not include unvested common shares subject to repurchase or cancellation. Diluted net income per share is computed using the weighted-average number of common shares and, if dilutive, potential common shares outstanding during the period. Potential common shares consist of the incremental common shares issuable upon the exercise of stock options, warrants, restricted shares, and unvested common shares subject to repurchase or cancellation. The dilutive effect of outstanding stock options, restricted shares, and warrants (see note 7) is not reflected in diluted earnings per share because we incurred net losses for the three months and six months ended June 30, 2015 and 2014, and the effect of including these potential common shares in the diluted earnings per share calculations would be anti-dilutive and are therefore not included in the calculations.

Accounts Receivable -Project Re

Accounts Receivable -Project Revenue and Reimbursable Project Costs	6 Months Ended
	Jun. 30, 2015
Accounts Receivable -Project Revenue and Reimbursable Project Costs [Text Block]	Note 3. Accounts Receivable – Project Revenue and Reimbursable Project Costs FANR and ENEC Projects The total accounts receivable from both the FANR and ENEC contracts was approximately $0.2 million and $0.5 million at June 30, 2015 and December 31, 2014, respectively. These amounts due from FANR and ENEC represent 66% of the accounts receivable reported at June 30, 2015 and 92% of the accounts receivable at December 31, 2014. Total unbilled accounts receivable of approximately $0.1 million was included in the accompanying condensed consolidated balance sheets and reported in accounts receivable at June 30, 2015 and December 31, 2014, and is for work that was billed to our clients in July 2015 and January 2015, respectively. Foreign currency transaction exchange losses and translation gains and losses for the three and six months ended June 30, 2015 and 2014, were not significant. Travel costs and other reimbursable costs under these contracts are reported in the accompanying condensed statements of operations as both revenue and cost of consulting services provided, and were not significant for the three and six months ended June 30, 2015 and 2014. The total travel and other reimbursable expenses that have not been reimbursed to us are included in total accounts receivable reported above from our consulting contracts and were not significant at June 30, 2015 and December 31, 2014. Under our agreements with ENEC and FANR, revenue will be recognized on a time and expense basis and fixed fee basis. We periodically discuss our consulting work with ENEC and FANR, who will review the work we perform, and our reimbursable travel expenses, and accept our monthly invoicing for services and reimbursable expenses. We expect the variation of revenue we earn from these contracts to continue.

Accounts Payable and Accrued Li

Accounts Payable and Accrued Liabilities	6 Months Ended
	Jun. 30, 2015
Accounts Payable and Accrued Liabilities [Text Block]	Note 4. Accounts Payable and Accrued Liabilities Accounts payable and accrued expenses (in millions) consisted of the following: June 30, December 31, 2015 2014 Trade payables $ 0.2 $ 0.3 Accrued expenses and other 0.3 0.4 Total $ 0.5 $ 0.7

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Jun. 30, 2015
Commitments and Contingencies [Text Block]	Note 5. Commitments and Contingencies Operating Leases On October 16, 2013, we entered into a 1 year sub-lease agreement with our current landlord for our current office space starting January 1, 2014 and terminating December 31, 2014. The monthly rent payment was approximately $32,000 plus additional charges. On January 1, 2015 we entered into a new sub-lease for our current office space for 38 months, with a monthly rent payment of approximately $32,000 per month plus additional charges with no rent charged for the initial 2 months of the lease term. The deferred rent liability was approximately $0.1 million at June 30, 2015. Total rent expense was approximately $0.1 million for the three months ended June 30, 2015 and 2014. Total rent expense was approximately $0.2 million for the six months ended June 30, 2015 and 2014. Litigation Our former Chief Financial Officer, filed a complaint against the Company and Seth Grae, President and Chief Executive Officer, with the Circuit Court of Fairfax County, Virginia (the “Fairfax County Complaint”), and a separate complaint against the Company with the U.S. Occupational Safety and Health Administration (the “OSHA Complaint”) on March 9, 2015. The Fairfax County Complaint contained two claims for damages. The first claim alleged that the Company and Mr. Grae made defamatory statements regarding the former Chief Financial Officer. The claim demands at least $1,000,000 in compensatory damages; costs, including reasonable fees for attorneys; and punitive damages of $1,000,000. The second claim alleges that the Company breached the former Chief Financial Officer’s employment contract by not paying the former Chief Financial Officer $15,507 for paid time off, and demands additional compensatory damages of at least $15,507. The OSHA Complaint alleges that the Company unlawfully retaliated against the former Chief Financial Officer for challenging allegedly improper actions of the Company by making allegedly defamatory statements and terminating him from his employment with the Company. The former Chief Financial Officer’s demand for damages is for back pay, front pay, and special damages. The complaint did not specify the amount of damages sought. The Company believes that all of the claims by the former Chief Financial Officer are without merit and intends to vigorously defend itself.

Research and Development Costs

Research and Development Costs	6 Months Ended
	Jun. 30, 2015
Research and Development Costs [Text Block]	Note 6. Research and Development Costs Research and development costs, included in the accompanying condensed consolidated statements of operations amounted to approximately $0.4 million and $0.6 million for the three months ended June 30, 2015 and 2014, respectively. Research and development costs, amounted to approximately $0.6 million and $1.1 million for the six months ended June 30, 2015 and 2014, respectively. We are in process of winding down our Moscow office operations, that we expect to be completed in 2015 and will focus our research and development work primarily in the United States, Canada, and Norway. There were no accrued liabilities related to the winding down of our Moscow office at June 30, 2015. On October 20, 2014, we announced the signing of an initial cooperation agreement with Canadian Nuclear Laboratories (“CNL”), a wholly owned subsidiary of Atomic Energy of Canada Limited, for fabrication and test reactor irradiation of Lightbridge’s patented next generation metallic nuclear fuel samples. Though we had initially planned for all of the work to take place at a single location in Chalk River, Ontario, Canada, subsequent to our announcement the Canadian government made an official decision to extend the operating life of the National Research Universal reactor at Chalk River only until the end of March 2018. This shorter than expected operating life extension would not be able to accommodate all of our entire anticipated schedule for irradiation testing of our metallic fuel samples. Consequently, our plan is to work with CNL on fabrication of our fuel samples at their Chalk River facilities, with full irradiation of the fabricated fuel samples to be performed separately in a pressurized water loop of the Halden research reactor located in Halden, Norway. The operating license of the Halden research reactor has recently been renewed through 2020 which fits well with our anticipated irradiation testing schedule. Our current plan is to have post-irradiation examination of the irradiated fuel samples performed on the same site in Norway. There is also the opportunity to utilize additional nearby hot cell facilities located in Studsvik, Sweden that are operated by the Swedish company Studsvik AB. We have consulting agreements with several consultants working on various projects for us, which total approximately $10,000 per month.

Stockholders' Equity

Stockholders' Equity	6 Months Ended
	Jun. 30, 2015
Stockholders' Equity [Text Block]	Note 7. Stockholders’ Equity At June 30, 2015 and December 31, 2014, there are 500,000,000 shares of authorized common stock. Total common stock outstanding at June 30, 2015 and December 31, 2014 was 18,082,874 shares. At June 30, 2015, there were 4,886,764 stock warrants and 3,245,213 stock options outstanding, totaling 26,214,851 of total stock and stock equivalents outstanding at June 30, 2015. At June 30, 2014 there are 500,000,000 shares of authorized common stock. Total common stock outstanding at June 30, 2014 was 15,071,536 shares. At June 30, 2014, there were 2,284,996 stock warrants and 2,143,686 stock options outstanding, all totaling 19,500,218 of total stock and stock equivalents outstanding at June 30, 2014. ATM Offering On June 11, 2015, the Company entered into an at-the-market issuance (“ATM”) sales agreement with MLV & Co. LLC ("MLV"), pursuant to which the Company may issue and sell shares of its common stock from time to time through MLV as the Company's sales agent. The issuance and sale of shares by the Company under the sales agreement are registered shares under the Company's shelf registration statement on Form S-3, as filed with the Securities and Exchange Commission on June 11, 2015 and declared effective by the Securities and Exchange Commission. There have been no stock sales made through the ATM for the period ended June 30, 2015 and up through the date of the issuance of these condensed consolidated financial statements. Registered Direct Offering and Outstanding Warrants November 12, 2014 Offering On November 12, 2014, we completed an offering, the (“Offering”) with one existing institutional investor pursuant to which the Company sold an aggregate of 2,878,516 shares of its common stock and warrants to purchase a total of 2,734,590 shares of its common stock for aggregate gross proceeds, before deducting fees to the Placement Agent and other estimated offering expenses payable by the Company, of approximately $5 million. The common stock and warrants were sold in fixed combinations, with each combination consisting of one share of common stock and a warrant to purchase 0.95 shares of common stock. The purchase price is $1.75 per fixed combination. The warrants will become exercisable six months and one day following the issuance date of the Offering, on May 18, 2015, and will remain exercisable for seven-and-a-half years from the date of issuance at an exercise price of $2.31 per share. The exercise price of the warrants is subject to adjustment in the case of stock splits, stock dividends, combinations of shares, and similar recapitalization transactions. The exercisability of the warrants may be limited if, upon exercise, the holder or any of its affiliates would beneficially own more than 4.99% of the Company's common stock. This limit may be increased to up to 19.99% upon no fewer than 60 days' notice to the Company. We received net proceeds of approximately $4.5 million after payment of certain fees and expenses related to the Offering. The allocation of the proceeds from the offering, based on the relative fair value of the common stock and the warrants, resulted in the allocation of approximately $2.7 million of the net proceeds to the common stock sold and approximately $1.8 million of the net proceeds to the warrants, which was recorded to additional paid-in capital-stock and stock equivalents. The value of the warrants issued was calculated by using the Black Scholes Valuation Model using the following assumptions: volatility 67%; risk-free interest rate of 2.07%; dividend yield of 0%, and expected term of 7.5 years. The volatility of the Company’s common stock was estimated by management based on the historical volatility of the trading history of the Company’s common stock. The risk-free interest rate was based on the Treasury Constant Maturity Rates published by the U.S. Federal Reserve for periods applicable to the expected life of the warrants. The expected dividend yield was based on the Company’s current and expected dividend policy and the expected term is equal to the contractual life of the warrants. All 2,734,590 of these warrants remained outstanding as of June 30, 2015. Outstanding Warrants June 30, 2015 2014 Issued to Investors on July 28,2010, entitling the holders to purchase 1,034,996 common shares in the Company at an exercise price of $9.00 per common share up to and including July 27, 2017 1,034,996 1,034,996 Issued to Investors on October 25, 2013, entitling the holders to purchase 1,250,000 common shares in the Company at an exercise price of $2.30 per common share up to and including April 24, 2021 1,117,178 1,250,000 Issued to Investors on November 17, 2014, entitling the holders to purchase 2,734,590 common shares in the Company at an exercise price of $2.31 per common share up to and including May 16, 2022 2,734,590 - Total 4,886,764 2,284,996 Exercise of Warrants – Q3-2014 On September 3, 2014, we issued 132,822 shares of our common stock upon the exercise of warrants issued in conjunction with the October 21, 2013 stock offering. We received $2.30 for each share or approximately $306,000. Stock-based Compensation – Stock Options and Restricted Stock Stock Plan On March 25, 2015, the Compensation Committee and Board of Directors approved the 2015 Equity Incentive Plan (the “Plan”) to authorize grants of (a) Incentive Stock Options, (b) Non-qualified Stock Options, (c) Stock Appreciation Rights, (d) Restricted Awards, (e) Performance Share Awards, and (f) Performance Compensation Awards to the employees, consultants, and directors of the Company. The Plan authorizes a total of 3,000,000 shares to be available for grant under the Plan. The Plan became effective upon ratification by the shareholders of the Company at the shareholders’ annual meeting on July 14, 2015. Other provisions are as follows: (i) Any shares of common stock granted in connection with Options and Stock Appreciation Rights shall be counted against this limit as one share for every one Stock Option or Stock Appreciation Right awarded. Any shares of common stock granted in connection with Awards other than Options and Stock Appreciation Rights shall be counted against this limit as two shares of common stock for every one share of common stock granted in connection with such Award; (ii) Subject to adjustment in accordance with the Plan, no Participant shall be granted, during any one year period, Options to purchase Common Stock and Stock Appreciation Rights with respect to more than two hundred fifty thousand (250,000) shares of Common Stock in the aggregate or any other Awards with respect to more than two hundred fifty thousand (250,000) shares of Common Stock in the aggregate. If an Award is to be settled in cash, the number of shares of Common Stock on which the Award is based shall count toward the individual share limit; and (iii) A ten percent shareholder shall not be granted an Incentive Stock Option unless the Option exercise price is at least 110% of the fair market value of the common stock at the grant date and the option is not exercisable after the expiration of five years from the grant date. Total stock options outstanding at June 30, 2015 and December 31, 2014, were 3,245,213 and 2,026,564, of which 2,312,149 and 1,564,257 of these options were vested at June 30, 2015 and December 31, 2014, respectively. Stock option expense was approximately $700,000 and $65,000 for the three months ended June 30, 2015 and 2014, respectively. Stock option expense was approximately $782,000 and $105,000 for the six months ended June 30, 2015 and 2014, respectively. 2015 Short-Term Non-Qualified Option Grants On April 8, 2015, the Compensation Committee and the Board of Directors granted short term non-qualified stock options totaling 463,192 and 148,845 stock options under the 2006 Stock Plan and the 2015 Equity Incentive Plan, respectively, to employees and consultants of the Company. On April 9, 2015, the Compensation Committee and the Board of Directors granted an additional 47,017 and 3,968 stock options under the 2006 Stock Plan and the 2015 Equity Incentive Plan, respectively, all with a strike price of $1.26. Also granted under the 2006 Stock Plan were 2,981, 1,775, and 1,310 non-qualified stock options on April 30, May 31, and June 30, 2015, respectively, as equity compensation in lieu of cash payroll with strike prices ranging from $1.12 to $1.23. These stock options vested immediately but the grants under the 2015 Equity Incentive Plan were only exercisable upon ratification of the Plan at the annual meeting of shareholders which took place on July 14, 2015. These stock options have an expected life of 5 years, and a contractual term of 10 years, a fair market value of between $0.76 and $0.86 per stock option, a risk free rate ranging between 1.37% to 1.63%, and volatility ranging between 86% to 88%, as measured on the grant date. The expected option term was calculated using the simplified method as we do not have sufficient historical option data to provide a better estimate of the expected option term. Under this method, the weighted-average expected life is presumed to be the average of the vesting term and the contractual term of the option, which results in a reduction of the estimated option value and consequently the stock option expense. The risk free rate was based on the US Treasury Yield Curve for the expected life of the options on the grant date. Expected dividends are estimated at $0.0, as we have never issued dividends and we have no current plans to issue dividends in the future. 2015 Long-Term Incentive Option Grants Employees and Consultants Option Grants On April 8, 2015, the Compensation Committee and the Board of Directors granted long term incentive stock options totaling 550,972, under the 2015 Equity Incentive Plan, the (“Plan”) to employees and consultants of the Company. These stock options vest 1/3 on each annual anniversary date over three years. These stock options have a strike price of $1.26, which was the closing price of the Company’s stock on the prior business day, and the stock options have a fair market value of $0.91, based on a risk free rate of 1.55%, volatility of 87%, and an expected life of six years, as measured on the grant date. The expected life is calculated using the simplified method as we do not have sufficient historical option data to provide a better estimate of the expected option term. These options have a 10 year contractual term. The risk free rate was based on the US Treasury Yield Curve for the expected life of the options on the grant date. Expected dividends are estimated at $0.0, as we have never issued dividends and we have no current plans to issue dividends in the future. We estimated future pre-vest forfeitures to be 1.5%, based on historical information. Director Option Grants On April 8, 2015, the Compensation Committee and the Board of Directors granted 112,996 long term non-qualified stock options under the 2015 Equity Incentive Plan to the Board of Directors of the Company. These stock options fully vest on the first annual anniversary date of the grant. These stock options have a strike price of $1.26, which was the closing price of the Company’s stock on the prior business day, and the stock options have a fair market value of $0.88, based on a risk free rate of 1.46%, volatility of 86%, and an expected life of 5.5 years. The expected life is calculated using the simplified method as we do not have any history to provide a better estimate of the expected option term. These options have a 10 year contractual term. The risk free rate was based on the US Treasury Yield Curve for the expected life of the options on the grant date. Expected dividends are estimated at $0.0, as we have never issued dividends and we have no current plans to issue dividends in the future. Grants to our consultants were re-measured as of June 30, 2015, and the fair market value of each option was $0.81 on the measurement date. This re-measured stock option expense for options issued to consultants was not significant. We estimated future pre-vest forfeitures to be 1.5%, based on historical information. 2014 Stock Option Grants On May 5, 2014, we granted 579,429 stock options to our employees, directors, and consultants. These stock options vest over three years for employees and consultants, and over one year for our directors. The fair market value of each option was $1.79 on the grant date, based on (1) The strike price of $2.55, the price of our stock at the close of the market on the grant date; (2) The expected life of the grant of 5 years which is equal to the term of the grant, as historically grants have only been exercised just before the term expires; (3) The risk free rate of 1.68% which is based on the treasury yield curve for a 5 year term as published by the U.S. Treasury for the grant date; (4) Volatility of 90.44%, as measured based on the expected life of the options, and (5) Expected dividends of $0.0, as we have never issued dividends and we have no current plans to issue dividends in the future. Grants to our consultants were re-measured as of June 30, 2015, and the fair market value of each option was $0.58 on the measurement date. We estimated future pre-vest forfeitures to be 1.5%, based on historical information. Stock option transactions to the employees, directors and consultants are summarized as follows for the six months ended June 30, 2015: Weighted Weighted Options Average Average Outstanding Exercise Grant Date Fair Price Value Beginning of the period 2,026,564 $ 9.19 $ 10.61 Granted 1,333,056 $ 1.26 $ 0.88 Exercised - - - Forfeited (114,407 ) $ 6.63 $ 6.06 Expired - $ - $ - End of the period 3,245,213 $ 6.03 $ 5.42 Options exercisable 2,312,149 $ 7.80 $ 7.15 Stock option transactions to the employees, directors and consultants are summarized as follows for the year ended December 31, 2014: Weighted Weighted Average Average Options Exercise Grant Date Fair Outstanding Price Value Beginning of the year 1,564,257 $ 11.16 $ 10.61 Granted 579,429 $ 2.55 $ 1.79 Exercised - - - Forfeited (117,122 ) $ - $ - Expired - $ - $ - End of the year 2,026,564 $ 9.19 $ 10.61 Options exercisable 1,564,257 $ 11.16 $ 10.61 The above tables include options issued and outstanding as of June 30, 2015, as follows: i) A total of 255,202 non-qualified 10 year options have been issued, and are outstanding, to advisory board members at exercise prices of $4.50 to $14.40 per share. ii) A total of 2,731,900 non-qualified 5 - 10 year options have been issued, and are outstanding, to our directors, officers, and employees at exercise prices of $1.12 to $23.85 per share. From this total, 1,198,526 options are outstanding to the Chief Executive Officer who is also a director, with remaining contractual lives of 0.4 years to 9.8 years. All other options issued to directors, officers, and employees have a remaining contractual life ranging from 1.1 years to 10.0 years. iii) A total of 258,111 non-qualified 5 - 10 year options have been issued, and are outstanding, to our consultants at exercise prices of 1.26 to $15.30 per share. The following table provides certain information with respect to the above-referenced stock options that are outstanding and exercisable at June 30, 2015: Stock Options Outstanding Stock Options Vested Weighted Weighted Average Average Remaining Weighted Remaining Weighted Contractual Number Average Contractual Number Average Life of Exercise Life of Exercise -Years Awards Price -Years Awards Price Exercise Prices $1.12 - $5.00 7.81 1,978,700 $ 1.86 7.59 1,045,636 $ 2.07 $5.01 - $12.90 3.55 668,177 $ 7.59 3.55 668,177 $ 7.59 $13.50 - $18.90 0.81 358,336 $ 14.17 0.81 358,336 $ 14.17 $19.20 - $23.85 0.63 240,000 $ 23.85 0.63 240,000 $ 23.85 Total 5.63 3,245,213 $ 6.03 4.65 2,312,149 $ 7.80 The following table provides certain information with respect to the above-referenced stock options that are outstanding and exercisable at December 31, 2014: Stock Options Outstanding Stock Options Vested Weighted Weighted Average Average Remaining Weighted Remaining Weighted Contractual Number Average Contractual Number Average Life of Exercise Life of Exercise -Years Awards Price -Years Awards Price Exercise Prices $2.55 - $5.00 4.26 645,644 $ 3.10 4.06 183,337 $ 4.50 $5.01 - $12.90 4.11 782,584 $ 7.45 4.11 782,584 $ 7.45 $13.50 - $18.90 1.30 358,336 $ 14.17 1.30 358,336 $ 14.17 $19.20 - $23.85 1.12 240,000 $ 23.85 1.12 240,000 $ 23.85 Total 3.31 2,026,564 $ 9.19 3.00 1,564,257 $ 11.16 The aggregate intrinsic value of stock options outstanding at June 30, 2015 and December 31, 2014, was $0. Intrinsic value is calculated based on the difference between the exercise price of the underlying awards and the quoted price of our common stock as of the reporting date ($1.12 and $1.55 per share as of the close on June 30, 2015 and December 31, 2014, respectively). We use the historical volatility of our stock price over the number of years that matches the expected life of our stock option grants or we use the historical volatility of our stock price since January 5, 2006, the date we announced that we were becoming a public company, to estimate the future volatility of our stock. At this time we do not believe that there is a better objective method to predict the future volatility of our stock for options with an expected term that is greater than our stock trading history. Prior to January 1, 2015, we estimated the life of our option awards based on the full contractual term of the option grant. To date we have had very few exercises of our option grants, and those stock option exercises had occurred just before the contractual expiration dates of the option awards. Since the strike price of most of our outstanding awards is greater than the price of our stock, generally awards have expired at the end of the contractual term. For options granted after January 1, 2015, we have applied the simplified method to estimate the expected term of our option grants as it is more likely that these options may be exercised prior to the end of the term. We estimate the effect of future forfeitures of our option grants based on an analysis of historical forfeitures of unvested grants, as we have no better objective basis for that estimate. The expense that we have recognized related to our grants includes the estimate for future pre-vest forfeitures. We will adjust the actual expense recognized due to future pre-vest forfeitures as they occur. We have estimated that 1.5% of our option grants will be forfeited prior to vesting. Assumptions used in the Black Scholes option-pricing model for the six months ended June 30, 2015 and the year ended December 31, 2014, were as follows: Six Months ended Year ended June 30, December 31, 2015 2014 Average risk-free interest rate 1.46% 1.68% Average expected life- years 5.5 5.0 Expected volatility 86.78% 90.44% Expected dividends 0 0 Stock-based compensation expense includes the expense related to (1) Grants of stock options, (2) grants of restricted stock, (3) Stock issued as consideration for some of the services provided by our directors and strategic advisory council members, and (4) stock issued in lieu of cash to pay bonuses to our employees and contractors. Grants of stock options and restricted stock are awarded to our employees, directors, consultants, and board members and we recognize the fair market value of these awards ratably as they are earned. The expense related to payments in stock for services is recognized as the services are provided. Stock-based compensation expense is recorded under the financial statement captions cost of services provided, general and administrative expenses and research and development expenses in the accompanying condensed consolidated statements of operations. For the three months ended June 30, 2015 and 2014, we recognized stock-based compensation of approximately $0.7 million and $0.1 million, respectively. For the six months ended June 30, 2015 and 2014, we recognized stock-based compensation of approximately $0.8 million and $0.1 million, respectively. Related income tax benefits were not recognized, as we incurred a tax loss for both years.

Business Segment Results

Business Segment Results	6 Months Ended
	Jun. 30, 2015
Business Segment Results [Text Block]	Note 8. Business Segment Results We have two principal business segments, which are (1) our technology business and (2) our consulting services business. These business segments were determined based on the nature of the operations and the services offered. Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief decision-makers, in deciding how to allocate resources and in assessing performance. Our Chief Executive Officer and Chief Financial Officer have been identified as the chief operating decision makers. Our chief operating decision makers direct the allocation of resources to operating segments based on the profitability, the cash flows, and the business plans of each respective segment. BUSINESS SEGMENT RESULTS – THREE MONTHS ENDED JUNE 30, 2015 AND 2014 Corporate and Consulting Technology Eliminations Total 2015 2014 2015 2014 2015 2014 2015 2014 Revenue 298,162 349,131 0 0 0 0 298,162 349,131 Segment Profit – Pre Tax (228,641) 2,131 (394,715) (624,448) (858,265) (1,032,791) (1,481,621) (1,655,108) Total Assets 247,144 408,231 883,775 764,714 2,900,566 1,899,181 4,031,485 3,072,126 Property Additions 0 0 0 0 0 0 0 0 Interest Expense 0 0 0 0 0 0 0 0 Depreciation 0 0 0 0 0 0 0 0 BUSINESS SEGMENT RESULTS – SIX MONTHS ENDED JUNE 30, 2015 AND 2014 Corporate and Consulting Technology Eliminations Total 2015 2014 2015 2014 2015 2014 2015 2014 Revenue 422,057 603,238 0 0 0 0 422,057 603,238 Segment Profit – Pre Tax (289,559) 83,040 (607,545) (1,056,535) (1,663,489) (2,115,535) (2,560,593) (3,089,030) Total Assets 247,144 408,231 883,775 764,714 2,900,566 1,899,181 4,031,485 3,072,126 Property Additions 0 0 0 0 0 0 0 0 Interest Expense 0 0 0 0 0 0 0 0 Depreciation 0 0 0 0 0 0 0 0

Subsequent Events

Subsequent Events	6 Months Ended
	Jun. 30, 2015
Subsequent Events [Text Block]	Note 9. Subsequent Events The Company has implemented the most recent FASB accounting pronouncement for reporting subsequent events. This standard establishes general standards of accounting for and disclosure of events that occur after the balance sheet date but before the consolidated financial statements are issued. The Company evaluated all events or transactions that occurred after June 30, 2015, up through the date these consolidated financial statements were issued and no subsequent events other than those listed below, occurred that required additional disclosure in the accompanying consolidated financial statements. On July 8, 2015, we announced the signing of an Umbrella Services Agreement with the Institute for Energy Technology (IFE) of Norway for irradiation testing of Lightbridge advanced metallic nuclear fuel samples under prototypic commercial reactor operating conditions in IFE's Halden research reactor, southeast of Oslo. The project's pre-irradiation scope includes irradiation-rig mechanical design, detailed neutronic and thermal-hydraulic calculations, and safety analyses with necessary regulatory approvals. The initial phase of irradiation testing is expected to begin in 2017 and continue for about three years to reach the burnup necessary for insertion of lead test assemblies (LTAs) in a commercial power reactor. The final phase of irradiation testing necessary for batch reloads and full cores operating with a 10% power uprate and a 24 -month cycle is expected to take an additional two years and be completed while LTAs have begun operating in the core of a commercial power reactor. The IFE umbrella services agreement is valid for 10 years.

Summary of Significant Accounti

Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Jun. 30, 2015
Basis of Consolidation [Policy Text Block]	Basis of Consolidation These consolidated financial statements include the accounts of Lightbridge, a Nevada corporation, and our wholly-owned subsidiaries, TPI, a Delaware corporation, Lightbridge International Holding LLC, a Delaware limited liability company, and our foreign branch offices. All significant intercompany transactions and balances have been eliminated in consolidation. We registered a branch office in the United Kingdom in 2008 called Lightbridge Advisors Limited (inactive) and we also established a branch office in Moscow, Russia, in July 2009, both of which are wholly owned by Lightbridge International Holding LLC at December 31, 2014. These branch offices will be closed in 2015. Translation gains and losses for the three and six months ended June 30, 2015 and 2014 were not significant. Foreign branches are winding down as of June 30, 2015.
Certain Risks, Uncertainties and Concentrations [Policy Text Block]	Certain Risks, Uncertainties and Concentrations We are an early stage company and will likely need additional funding by way of strategic alliances, further offerings of equity securities, an offering of debt securities, or a financing through a bank in order to support the remaining research and development activities required to further enhance and complete the development of our fuel products to a commercial stage. Currently, we are working on consulting revenue opportunities with the overall goal of increasing our profitability and cash flow. We participate in a government-regulated industry. Our operating results are affected by a wide variety of factors including decreases in the use or public favor of nuclear power, the ability of our technology to safeguard the production of nuclear power and our ability to safeguard our patents and intellectual property from competitors. Due to these factors, we may experience substantial period-to-period fluctuations in our future operating results. Potentially, a loss of a key officer, key management, and other personnel could impair our ability to successfully execute our business strategy, particularly when these individuals have acquired specialized knowledge and skills with respect to nuclear power and our operations. Our future operations and earnings currently depend on the results of the Company’s operations outside the United States. There can be no assurance that the Company will be able to successfully continue to conduct such operations, and a failure to do so would have a material adverse effect on the Company’s research and development activities, financial position, results of operations, and cash flows. Also, the success of the Company’s operations will be subject to other numerous contingencies, some of which are beyond management’s control. These contingencies include general and regional economic conditions, competition, changes in regulations, changes in accounting and taxation standards, inability to achieve overall long-term goals, future impairment charges and global or regional catastrophic events. Because the Company is dependent on its international operations for almost all its revenue, the Company may be subject to various additional political, economic, and other uncertainties. Accounts receivable are typically unsecured and are primarily derived from revenues earned from customers located in the Middle East. We perform ongoing evaluations to determine customer credit and we limit the amount of credit we extend, but generally we do not require collateral from our customers. We maintain reserves for estimated credit losses if necessary, however, no reserve has been set up at June 30, 2015 and 2014, as we have not incurred any credit losses from our customers to date. Approximately 60% and 80% of the total revenues reported for the three months ended June 30, 2015 and 2014, respectively, were from the ENEC and FANR contracts. The ENEC and FANR contracts were approximately 60% and substantially all of our consulting revenues for the six months ended June 30, 2015 and 2014, respectively. Contracts with one other customer constituted approximately 40% and 20% of the total revenues reported for the three months ended June 30, 2015 and 2014, respectively, and approximately 40% and 20% of the total revenues reported for the six months ended June 30, 2015 and 2014, respectively.
Revenue Recognition [Policy Text Block]	Revenue Recognition Consulting Business Segment At the present time, we derive all of our revenue from our consulting business segment on a time and expense basis as provided, by offering consulting services to governments outside the United States planning to create or expand electricity generation capabilities using nuclear power plants. Our fee structure for each client engagement is dependent on a number of variables, including the size of the client, the complexity, the level of the opportunity for us to improve the client’s electrical generation capabilities using nuclear power plants, and other factors. The accounting policy we use to recognize revenue depends on the terms and conditions of the specific contract. Revenues from the Executive Affairs Authority (“EAA”) of Abu Dhabi, one of the member Emirates of the UAE, and the related entities, ENEC and FANR, are billed on both a time and expense basis and on a fixed contract basis with revenue recognized based on the acceptance of defined contract deliverables. Certain customer arrangements require evaluation of the criteria outlined in the accounting standards for reporting revenue “ Gross as a Principal Versus Net as an Agent ” in determining whether it is appropriate to record the gross amount of revenue and related costs, or the net amount earned as agent fees. Generally, when we are primarily obligated in a transaction, revenue is recorded on a gross basis. Other factors that we consider in determining whether to recognize revenue on a gross versus net basis include our assumption of credit risk, latitude in establishing prices, our determination of service specifications, and our involvement in the provision of services. We have determined, based on the credit risk that we bear for collecting consulting fees, travel costs, and other reimbursable costs from our customers, that in 2015 and 2014 we acted as a principal, and therefore we are recognizing as revenue all travel costs and other reimbursable costs billed to our customers. Cost of consulting services includes labor, travel expenses, stock-based compensation and other related consulting costs. Technology Business Segment Once our nuclear fuel designs have advanced to a commercially usable stage by a fuel fabricator and/or nuclear plant owner/operator, we will seek to license our technology to them or to major government contractors working for the applicable government. We expect that our revenue from these license fees will be recognized on a straight-line basis over the expected period of the related license term.
Stock-Based Compensation [Policy Text Block]	Stock-Based Compensation The stock-based compensation expense incurred by Lightbridge for employees and directors in connection with its stock option plan is based on the employee model of ASC 718, and the fair market value of the options is measured at the grant date. Under ASC 718 employee is defined as, “An individual over whom the grantor of a share-based compensation award exercises or has the right to exercise sufficient control to establish an employer-employee relationship based on common law as illustrated in case law and currently under U.S. Tax Regulations.” Our advisory board members and consultants do not meet the employer-employee relationship as defined by the IRS and therefore are accounted for under ASC 505-50. ASC 505-50-30-11 (previously EITF 96-18) further provides that an issuer shall measure the fair value of the equity instruments in these transactions using the stock price and other measurement assumptions as of the earlier of the following dates, referred to as the measurement date: i. The date at which a commitment for performance by the counterparty to earn the equity instruments is reached (a performance commitment); and ii. The date at which the counterparty’s performance is complete. We have elected to use the Black-Scholes pricing model to determine the fair value of stock options on the measurement date of the grant. Restricted stock units are measured based on the fair market values of the underlying stock on the measurement date of the grant. Shares that are issued to officers on the exercise dates of their stock options may be issued net of the statutory withholding requirements to be paid by us on behalf of our employees. As a result, the actual number of shares issued will be fewer than the actual number of shares exercised under the stock option. We recognize stock-based compensation using the straight-line method over the requisite service period.
Cash and Cash Equivalents and Restricted Cash [Policy Text Block]	Cash and Cash Equivalents and Restricted Cash We invest our excess cash in money market mutual funds. We classify all highly liquid investments with stated maturities of three months or less from date of purchase as cash equivalents and all highly liquid investments with stated maturities of greater than three months as marketable securities. We hold cash balances in excess of the federally insured limits of $250,000 with one prominent financial institution. We deem this credit risk not to be significant as our cash is held by a major prominent financial institution. Total cash and cash equivalents held in checking accounts and a money market core cash account, as reported on the accompanying consolidated condensed balance sheets, totaled approximately $2.4 million and $4.2 million at June 30, 2015 and December 31, 2014, respectively. Restricted cash represents cash being held by the same prominent financial institution that is being used as collateral for our corporate credit cards and future letters of credit that we may issue to some of our foreign customers. The total balance of our restricted cash at June 30, 2015 and December 31, 2014, was approximately $0.3 million.
Trade Accounts Receivable [Policy Text Block]	Trade Accounts Receivable We record accounts receivable at the invoiced amount and we do not charge interest. We review the accounts receivable by amounts due from customers which are past due, to identify specific customers with known disputes or collectability issues. In determining the amount of the reserve, we make judgments about the creditworthiness of significant customers based on ongoing credit evaluations. We will also maintain a sales allowance to reserve for potential credits issued to customers. We will determine the amount of the reserve based on historical credits issued. There was no provision for doubtful accounts recorded at June 30, 2015 and December 31, 2014, as we have not experienced any bad debts from any of our customers.
Foreign Currency [Policy Text Block]	Foreign Currency The functional currency of our international branches is the local currency. We translate the financial statements of these branches to U.S. dollars using period-end rates of exchange for assets and liabilities, and average rates of exchange for revenues, costs, and expenses. The translation gains/losses for our branch office in Russia were not significant for the three and six months ended June 30, 2015 and 2014.
Patents and Legal Costs [Policy Text Block]	Patents and Legal Costs Patents are stated on the accompanying condensed consolidated balance sheets at cost. The costs of the patents, once placed in service, will be amortized on a straight-line basis over their estimated useful lives or the remaining legal lives of the patents, whichever is shorter. The amortization periods for our patents can range between 17 and 20 years if placed into service at the beginning of their legal lives. Our patents have not been placed in service for the three and six months ended June 30, 2015 and 2014. Legal costs are expensed as incurred except for legal costs to file for patent protection, which are capitalized and reported as patents on the accompanying condensed consolidated balance sheets.
Impairment of long-lived assets [Policy Text Block]	Impairment of long-lived assets Long-lived assets of the Company are reviewed for impairment whenever events or circumstances indicate that the carrying amount of assets may not be recoverable. The Company recognizes an impairment loss when the sum of expected undiscounted future cash flows is less than the carrying amount of the asset. The amount of impairment is measured as the difference between the asset’s estimated fair value and its book value. The Company did not consider it necessary to record any impairment charges for the three and six months ended June 30, 2015 and 2014.
Research, Development and Related Expenses [Policy Text Block]	Research, Development and Related Expenses These costs from our Technology business segment are charged to operations in the period incurred and are shown on a separate line on the accompanying condensed consolidated statements of operations.
Segment Reporting [Policy Text Block]	Segment Reporting We use the “management approach” in determining reportable operating segments. The management approach considers the internal organization and reporting used by our chief decision makers for making operating decisions and assessing performance, as the source for determining our reportable segments. We have determined that we have two operating segments as defined by the FASB accounting pronouncement, “ Disclosures about Segments of an Enterprise and Related Information
Recent Accounting Pronouncements [Policy Text Block]	Recent Accounting Pronouncements Revenue Recognition In May 2014, the FASB issued guidance on revenue from contracts with customers that will supersede most current revenue recognition guidance, including industry-specific guidance. The underlying principle is that an entity will recognize revenue to depict the transfer of goods or services to customers at an amount that the entity expects to be entitled to in exchange for those goods or services. The guidance provides a five-step analysis of transactions to determine when and how revenue is recognized. Other major provisions include capitalization of certain contract costs, consideration of time value of money in the transaction price, and allowing estimates of variable consideration to be recognized before contingencies are resolved in certain circumstances. The guidance also requires enhanced disclosures regarding the nature, amount, timing and uncertainty of revenue and cash flows arising from an entity’s contracts with customers. The guidance is effective for the interim and annual periods beginning on or after December 15, 2017, (early adoption is not permitted). The guidance permits the use of either a retrospective or cumulative effect transition method. Going Concern In August 2014, FASB issued guidance that requires management to perform interim and annual assessments of an entity’s ability to continue as a going concern within one year of the date the financial statements are issued. An entity must provide certain disclosures if conditions or events raise substantial doubt about the entity’s ability to continue as a going concern. The updated accounting guidance will be effective for the Company on January 1, 2017, and early adoption is permitted. The Company will evaluate the going concern considerations in this guidance upon adoption. The Company does not expect the adoption of any recent accounting pronouncements to have a material impact on its financial statements.

Accounts Payable and Accrued 16

Accounts Payable and Accrued Liabilities (Tables)	6 Months Ended
	Jun. 30, 2015
Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]	June 30, December 31, 2015 2014 Trade payables $ 0.2 $ 0.3 Accrued expenses and other 0.3 0.4 Total $ 0.5 $ 0.7

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	6 Months Ended	12 Months Ended
	Jun. 30, 2015	Dec. 31, 2014
Schedule of Warrants Outstanding [Table Text Block]	June 30, 2015 2014 Issued to Investors on July 28,2010, entitling the holders to purchase 1,034,996 common shares in the Company at an exercise price of $9.00 per common share up to and including July 27, 2017 1,034,996 1,034,996 Issued to Investors on October 25, 2013, entitling the holders to purchase 1,250,000 common shares in the Company at an exercise price of $2.30 per common share up to and including April 24, 2021 1,117,178 1,250,000 Issued to Investors on November 17, 2014, entitling the holders to purchase 2,734,590 common shares in the Company at an exercise price of $2.31 per common share up to and including May 16, 2022 2,734,590 - Total 4,886,764 2,284,996
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]	Weighted Weighted Options Average Average Outstanding Exercise Grant Date Fair Price Value Beginning of the period 2,026,564 $ 9.19 $ 10.61 Granted 1,333,056 $ 1.26 $ 0.88 Exercised - - - Forfeited (114,407 ) $ 6.63 $ 6.06 Expired - $ - $ - End of the period 3,245,213 $ 6.03 $ 5.42 Options exercisable 2,312,149 $ 7.80 $ 7.15	Weighted Weighted Average Average Options Exercise Grant Date Fair Outstanding Price Value Beginning of the year 1,564,257 $ 11.16 $ 10.61 Granted 579,429 $ 2.55 $ 1.79 Exercised - - - Forfeited (117,122 ) $ - $ - Expired - $ - $ - End of the year 2,026,564 $ 9.19 $ 10.61 Options exercisable 1,564,257 $ 11.16 $ 10.61
Schedule of Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]	Stock Options Outstanding Stock Options Vested Weighted Weighted Average Average Remaining Weighted Remaining Weighted Contractual Number Average Contractual Number Average Life of Exercise Life of Exercise -Years Awards Price -Years Awards Price Exercise Prices $1.12 - $5.00 7.81 1,978,700 $ 1.86 7.59 1,045,636 $ 2.07 $5.01 - $12.90 3.55 668,177 $ 7.59 3.55 668,177 $ 7.59 $13.50 - $18.90 0.81 358,336 $ 14.17 0.81 358,336 $ 14.17 $19.20 - $23.85 0.63 240,000 $ 23.85 0.63 240,000 $ 23.85 Total 5.63 3,245,213 $ 6.03 4.65 2,312,149 $ 7.80	Stock Options Outstanding Stock Options Vested Weighted Weighted Average Average Remaining Weighted Remaining Weighted Contractual Number Average Contractual Number Average Life of Exercise Life of Exercise -Years Awards Price -Years Awards Price Exercise Prices $2.55 - $5.00 4.26 645,644 $ 3.10 4.06 183,337 $ 4.50 $5.01 - $12.90 4.11 782,584 $ 7.45 4.11 782,584 $ 7.45 $13.50 - $18.90 1.30 358,336 $ 14.17 1.30 358,336 $ 14.17 $19.20 - $23.85 1.12 240,000 $ 23.85 1.12 240,000 $ 23.85 Total 3.31 2,026,564 $ 9.19 3.00 1,564,257 $ 11.16
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	Six Months ended Year ended June 30, December 31, 2015 2014 Average risk-free interest rate 1.46% 1.68% Average expected life- years 5.5 5.0 Expected volatility 86.78% 90.44% Expected dividends 0 0

Business Segment Results (Table

Business Segment Results (Tables) - Jun. 30, 2015	Total	Total
Schedule of Segment Reporting Information, by Segment [Table Text Block]	Corporate and Consulting Technology Eliminations Total 2015 2014 2015 2014 2015 2014 2015 2014 Revenue 298,162 349,131 0 0 0 0 298,162 349,131 Segment Profit – Pre Tax (228,641) 2,131 (394,715) (624,448) (858,265) (1,032,791) (1,481,621) (1,655,108) Total Assets 247,144 408,231 883,775 764,714 2,900,566 1,899,181 4,031,485 3,072,126 Property Additions 0 0 0 0 0 0 0 0 Interest Expense 0 0 0 0 0 0 0 0 Depreciation 0 0 0 0 0 0 0 0	Corporate and Consulting Technology Eliminations Total 2015 2014 2015 2014 2015 2014 2015 2014 Revenue 422,057 603,238 0 0 0 0 422,057 603,238 Segment Profit – Pre Tax (289,559) 83,040 (607,545) (1,056,535) (1,663,489) (2,115,535) (2,560,593) (3,089,030) Total Assets 247,144 408,231 883,775 764,714 2,900,566 1,899,181 4,031,485 3,072,126 Property Additions 0 0 0 0 0 0 0 0 Interest Expense 0 0 0 0 0 0 0 0 Depreciation 0 0 0 0 0 0 0 0

Basis of Presentation, Summar19

Basis of Presentation, Summary of Significant Accounting Policies and Nature of Operations (Narrative) (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014	Dec. 31, 2014	Dec. 31, 2013
Metallic fuel power uprate percentage			10.00%
Operating cycle length - Westinghouse-type			24 months
Stock based compensation			$ 782,036	$ 125,297
Cash and Cash Equivalents, at Carrying Value	$ 2,371,266	$ 987,954	2,371,266	987,954	$ 4,220,225	$ 3,672,877
Research and Development Expense	394,715	$ 624,448	$ 607,545	$ 1,056,434
Minimum [Member]
Amortization period for patents			17 years
Maximum [Member]
Federally insured cash limit	250,000		$ 250,000
Amortization period for patents			20 years
Approximations [Member]
Cash and Cash Equivalents, at Carrying Value	2,400,000		$ 2,400,000		4,200,000
Restricted Cash	$ 300,000		$ 300,000		$ 300,000
Approximations [Member] | ENEC and FANR Projects [Member]
Concentration Risk, Percentage	60.00%	80.00%	60.00%
Approximations [Member] | Customer Contract [Member]
Concentration Risk, Percentage	40.00%	20.00%	20.00%	40.00%

Accounts Receivable -Project 20

Accounts Receivable -Project Revenue and Reimbursable Project Costs (Narrative) (Details) - Approximations [Member] - USD ($) $ in Millions	Jun. 30, 2015	Dec. 31, 2014
Unbilled receivable	$ 0.1	$ 0.1
ENEC and FANR Projects [Member]
Accounts Receivable	$ 0.2	$ 0.5
Portion of accounts receivable	66.00%	92.00%

Commitments and Contingencies (

Commitments and Contingencies (Narrative) (Details) - USD ($)	1 Months Ended		3 Months Ended		6 Months Ended
	Jan. 31, 2015	Oct. 16, 2013	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Operating lease term	38 months	1 year
Fairfax County Complaint 1 [Member]
Compensatory damages sought					$ 1,000,000
Fairfax County Complaint 2 [Member]
Compensatory damages sought					15,507
Approximations [Member]
Monthly rental fees	$ 32,000	$ 32,000
Deferred rent liability			$ 100,000		100,000
Rent expense			$ 100,000	$ 100,000	$ 200,000	$ 200,000

Research and Development Costs

Research and Development Costs (Narrative) (Details) - Approximations [Member] - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Research and development costs	$ 400,000	$ 600,000	$ 600,000	$ 1,100,000
Consulting agreement monthly payments			$ 10,000

Stockholders' Equity (Narrative

Stockholders' Equity (Narrative) (Details) - USD ($)	Apr. 09, 2015	Apr. 08, 2015	Nov. 12, 2014	Sep. 03, 2014	May. 05, 2014	May. 31, 2015	Apr. 30, 2015	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014	Dec. 31, 2014	Dec. 31, 2013
Common Stock, Shares Authorized								500,000,000	500,000,000	500,000,000	500,000,000	500,000,000
Common Stock, Shares, Outstanding								18,082,874	15,071,536	18,082,874	15,071,536	18,082,874
Class of Warrant or Right, Outstanding								4,886,764	2,284,996	4,886,764	2,284,996
Number of options outstanding								3,245,213	2,143,686	3,245,213	2,143,686	2,026,564	1,564,257
Number of options vested and expected to vest outstanding								2,312,149		2,312,149		1,564,257
Aggregate intrinsic value								$ 0		$ 0		$ 0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Intrinsic Value								$ 1.12		$ 1.12		$ 1.55
Restricted stock grants estimated forfeiture amount								1.50%		1.50%
Share based compensation										$ 782,036	$ 125,297
Common Stock issued								18,082,874		18,082,874		18,082,874
Volitility rate										86.78%		90.44%
Risk-free interest rate										1.46%		1.68%
Dividend yield										0.00%		0.00%
Expected term										5 years 6 months		5 years
Stock options granted										1,333,056		579,429
Fair value of stock options granted												$ 10.61	$ 10.61
Approximations [Member]
Stock option expense								$ 700,000	$ 65,000	$ 782,000	$ 105,000
Chief Executive Officer [Member]
Non-qualified stock options										1,198,526
Issuance of 255,202 non-qualified 10 year options [Member]
Non-qualified stock options										255,202
Contractural lives										10 years
Lower Limit										$ 4.50
Upper Limit										$ 14.40
Registered Direct Offering and Outstanding Warrants [Member]
Equity Issuance, Per Share Amount				$ 2.30
Common Stock issued				132,822
Proceeds from Issuance of Common Stock				$ 306,000
May 5, 2014 Stock Options Granted [Member]
Volitility rate					90.44%
Risk-free interest rate					1.68%
Dividend yield					0.00%
Expected term					5 years
Strike Price					$ 2.55
Stock options granted					579,429
Fair value of stock options granted					$ 1.79
Fair market value on measurement date					$ 0.58
Pre-vesting forfeiture rate					1.50%
Issuance of 2,731,900 non-qualified 5-10 year options [Member]
Non-qualified stock options										2,731,900
Lower Limit										$ 1.12
Upper Limit										$ 23.85
Issuance of 258,111 non-qualified 5-10 year options [Member]
Non-qualified stock options										258,111
Lower Limit										$ 1.26
Upper Limit										$ 15.30
November 12, 2014 Offering [Member]
Proceeds from Issuance of Common Stock			$ 5,000,000
Common stock and warrants sold			$ 2,878,516
Common stock to be purchased in the Offering			2,734,590
Shares of common stock to be purchased by fixed combination			0.95
Purchase price of fixed combination			$ 1.75
Warrant exercise price			$ 2.31
November 12, 2014 Offering [Member] | Approximations [Member]
Net proceeds from the Offering received after payments of fees and expenses			$ 4,500,000
Amount allocated from the Offering to common stock			2,700,000
Amount allocated from the Offering to warrants			$ 1,800,000
Issued to Investors on July 28, 2010 [Member]
Class of Warrant or Right, Outstanding								1,034,996	1,034,996	1,034,996	1,034,996
Common stock to be purchased in the Offering								1,034,996		1,034,996
Warrant exercise price										$ 9
Issued to Investors on October 25, 2013 [Member]
Class of Warrant or Right, Outstanding								1,117,178	1,250,000	1,117,178	1,250,000
Common stock to be purchased in the Offering								1,250,000		1,250,000
Warrant exercise price										$ 2.30
Issued to Investors on November 17, 2014 [Member]
Class of Warrant or Right, Outstanding								2,734,590	0	2,734,590	0
Common stock to be purchased in the Offering								2,734,590		2,734,590
Warrant exercise price										$ 2.31
2015 Equity Incentive Plan [Member]
Common Stock, Shares Authorized								3,000,000		3,000,000
Shares of Common Stock limit on stock options										250,000
2015 Equity Incentive Plan [Member] | Directors [Member]
Contractural lives		10 years
Volitility rate		86.00%
Risk-free interest rate		1.46%
Expected term		5 years 6 months
Strike Price		$ 1.26
Fair value of stock options granted		$ 0.88						$ 0.81		$ 0.81
Pre-vesting forfeiture rate		1.50%
Expected dividends		$ 0
2015 Short-Term Non-Qualified Option Grants [Member]
Non-qualified stock options						1,775	2,981			1,310
Contractural lives		10 years
Lower Limit		$ 0.76
Upper Limit		$ 0.86
Expected term		5 years
Strike Price		$ 1.26
Expected dividends		$ 0
2015 Long-Term Incentive Option Grants [Member] | Employees and Consultants [Member]
Contractural lives		10 years
Volitility rate		87.00%
Risk-free interest rate		1.55%
Expected term		6 years
Strike Price		$ 1.26
Fair value of stock options granted		$ 0.91
Pre-vesting forfeiture rate		1.50%
Expected dividends		$ 0
Stock options granted		550,972
2015 Long-Term Incentive Option Grants [Member] | Directors [Member]
Non-qualified stock options		112,996
Minimum [Member] | Chief Executive Officer [Member]
Contractural lives										4 months 24 days
Minimum [Member] | Directors, Officers and Employees [Member]
Contractural lives										1 year 1 month 6 days
Minimum [Member] | Issuance of 2,731,900 non-qualified 5-10 year options [Member]
Contractural lives										5 years
Minimum [Member] | Issuance of 258,111 non-qualified 5-10 year options [Member]
Contractural lives										5 years
Minimum [Member] | November 12, 2014 Offering [Member]
Maximum common stock ownership to be eligible for exercise of warrants			4.99%
Minimum [Member] | 2015 Short-Term Non-Qualified Option Grants [Member]
Risk-free interest rate		1.37%
Dividend yield		86.00%
Strike Price		$ 1.12
Maximum [Member] | Chief Executive Officer [Member]
Contractural lives										9 years 9 months 18 days
Maximum [Member] | Directors, Officers and Employees [Member]
Contractural lives										10 years
Maximum [Member] | Issuance of 2,731,900 non-qualified 5-10 year options [Member]
Contractural lives										10 years
Maximum [Member] | Issuance of 258,111 non-qualified 5-10 year options [Member]
Contractural lives										10 years
Maximum [Member] | November 12, 2014 Offering [Member]
Maximum common stock ownership to be eligible for exercise of warrants			19.99%
Maximum [Member] | 2015 Short-Term Non-Qualified Option Grants [Member]
Risk-free interest rate		1.63%
Dividend yield		88.00%
Strike Price		$ 1.23
Stock and Stock Equivalents [Member]
Common Stock, Shares, Outstanding								26,214,851	19,500,218	26,214,851	19,500,218
Stock-based compensation [Member] | Approximations [Member]
Share based compensation								$ 700,000	$ 100,000	$ 800,000	$ 100,000
Warrants [Member] | November 12, 2014 Offering [Member]
Class of Warrant or Right, Outstanding								2,734,590		2,734,590
Volitility rate			67.00%
Risk-free interest rate			2.07%
Dividend yield			0.00%
Expected term			7 years 6 months
2006 Stock Plan [Member] | 2015 Short-Term Non-Qualified Option Grants [Member]
Non-qualified stock options	47,017
2006 Stock Plan [Member] | 2015 Short-Term Non-Qualified Option Grants [Member] | Employees and Consultants [Member]
Non-qualified stock options		463,192
2015 Equity Incentive Plan [Member] | 2015 Short-Term Non-Qualified Option Grants [Member]
Non-qualified stock options	3,968
2015 Equity Incentive Plan [Member] | 2015 Short-Term Non-Qualified Option Grants [Member] | Employees and Consultants [Member]
Non-qualified stock options		148,845

Subsequent Events (Narrative) (

Subsequent Events (Narrative) (Details)	6 Months Ended
	Jun. 30, 2015
Subsequent Event [Member]
IFE Umbrella service agreement	10 years

Schedule of Accounts Payable an

Schedule of Accounts Payable and Accrued Liabilities (Details) - USD ($)	Jun. 30, 2015	Dec. 31, 2014
Total	$ 452,571	$ 653,668
Approximations [Member]
Trade payables	200,000	300,000
Accrued expenses and other	300,000	400,000
Total	$ 500,000	$ 700,000

Schedule of Warrants Outstandin

Schedule of Warrants Outstanding (Details) - $ / shares	6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014
Warrants Outstanding	4,886,764	2,284,996
Issued to Investors on July 28, 2010 [Member]
Warrants Outstanding	1,034,996	1,034,996
Exercise price	$ 9
Common stock to be purchased in the Offering	1,034,996
Issued to Investors on October 25, 2013 [Member]
Warrants Outstanding	1,117,178	1,250,000
Exercise price	$ 2.30
Common stock to be purchased in the Offering	1,250,000
Issued to Investors on November 17, 2014 [Member]
Warrants Outstanding	2,734,590	0
Exercise price	$ 2.31
Common stock to be purchased in the Offering	2,734,590

Schedule of Share-based Compens

Schedule of Share-based Compensation, Stock Options, Activity (Details) - $ / shares	6 Months Ended	12 Months Ended
	Jun. 30, 2015	Dec. 31, 2014
Beginning of Period	2,026,564	1,564,257
Weighted Average Exercise Price Beginning of the Year	$ 9.19	$ 11.16
Weighted Average Fair Value Stock Options Beginning of the Year	$ 10.61	$ 10.61
Stock options granted	1,333,056	579,429
Weighted Average Exercise Price Stock Options Granted	$ 1.26	$ 2.55
Weighted Average Fair Value Stock Options Granted	$ 0.88	$ 1.79
Exercised	0	0
Weighted Average Exercise Price	$ 0	$ 0
Weighted Average Fair Value Stock Options Exercised	$ 0	$ 0
Forfeited	(114,407)	(117,122)
Weighted Average Exercise Price Stock Options Forfeited	$ 6.63	$ 0
Weighted Average Fair Value Stock Options Forfeited	$ 6.06	$ 0
Expired	0	0
Weighted Average Exercise Price Stock Options Expired	$ 0	$ 0
Weighted Average Fair Value Stock Options Expired	$ 0	$ 0
End of year	3,245,213	2,026,564
Weighted Average Exercise End of Year	$ 6.03	$ 9.19
Weighted Average Fair Value Stock Options End of Year	$ 5.42	$ 10.61
Options exercisable	2,312,149	1,564,257
Weighted Average Exercise Price Options exercisable	$ 7.80	$ 11.16
Weighted Average Fair Value Options exerciseable	$ 7.15	$ 10.61

Schedule of Disclosure of Share

Schedule of Disclosure of Share-based Compensation Arrangements by Share-based Payment Award (Details) - $ / shares	6 Months Ended	12 Months Ended
	Jun. 30, 2015	Dec. 31, 2014	Jun. 30, 2014	Dec. 31, 2013
Weighted Average Remaining Contractural Life - Years	5 years 7 months 17 days	3 years 3 months 22 days
Number of options outstanding	3,245,213	2,026,564	2,143,686	1,564,257
Weighted Average Exercise Price Stock Options Outstanding	$ 6.03	$ 9.19		$ 11.16
Number of Awards Vested	2,312,149	1,564,257
Weighted Average Exercise Price	$ 7.80	$ 11.16
Weighted Average Remaining Contractual Life of Stock Options Vested	4 years 7 months 24 days	3 years
Range 1 [Member]
Exercise price lower range limit	$ 1.12	$ 2.55
Exercise price upper range limit	$ 5	$ 5
Weighted Average Remaining Contractural Life - Years	7 years 9 months 22 days	4 years 3 months 4 days
Number of options outstanding	1,978,700	645,644
Weighted Average Exercise Price Stock Options Outstanding	$ 1.86	$ 3.10
Number of Awards Vested	1,045,636	183,337
Weighted Average Exercise Price	$ 2.07	$ 4.50
Weighted Average Remaining Contractual Life of Stock Options Vested	7 years 7 months 2 days	4 years 22 days
Range 2 [Member]
Exercise price lower range limit	$ 5.01	$ 5.01
Exercise price upper range limit	$ 12.90	$ 12.90
Weighted Average Remaining Contractural Life - Years	3 years 6 months 18 days	4 years 1 month 10 days
Number of options outstanding	668,177	782,584
Weighted Average Exercise Price Stock Options Outstanding	$ 7.59	$ 7.45
Number of Awards Vested	668,177	782,584
Weighted Average Exercise Price	$ 7.59	$ 7.45
Weighted Average Remaining Contractual Life of Stock Options Vested	3 years 6 months 18 days	4 years 1 month 10 days
Range 3 [Member]
Exercise price lower range limit	$ 13.50	$ 13.50
Exercise price upper range limit	$ 18.90	$ 18.90
Weighted Average Remaining Contractural Life - Years	9 months 22 days	1 year 3 months 18 days
Number of options outstanding	358,336	358,336
Weighted Average Exercise Price Stock Options Outstanding	$ 14.17	$ 14.17
Number of Awards Vested	358,336	358,336
Weighted Average Exercise Price	$ 14.17	$ 14.17
Weighted Average Remaining Contractual Life of Stock Options Vested	9 months 22 days	1 year 3 months 18 days
Range 4 [Member]
Exercise price lower range limit	$ 19.20	$ 19.20
Exercise price upper range limit	$ 23.85	$ 23.85
Weighted Average Remaining Contractural Life - Years	7 months 17 days	1 year 1 month 13 days
Number of options outstanding	240,000	240,000
Weighted Average Exercise Price Stock Options Outstanding	$ 23.85	$ 23.85
Number of Awards Vested	240,000	240,000
Weighted Average Exercise Price	$ 23.85	$ 23.85
Weighted Average Remaining Contractual Life of Stock Options Vested	7 months 17 days	1 year 1 month 13 days

Schedule of Share-based Payment

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Details) - Award Type [Domain]	6 Months Ended	12 Months Ended
	Jun. 30, 2015	Dec. 31, 2014
Average risk-free interest rate	1.46%	1.68%
Average expected life- years	5 years 6 months	5 years
Expected volatility	86.78%	90.44%
Expected dividends	0.00%	0.00%

Schedule of Segment Reporting I

Schedule of Segment Reporting Information, by Segment (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014	Dec. 31, 2014
Revenue	$ 298,162	$ 349,131	$ 422,057	$ 603,238
Segment Profit - Pre Tax	(1,481,621)	(1,655,108)	(2,560,593)	(3,089,030)
Total Assets	4,031,485	3,072,126	4,031,485	3,072,126	$ 6,053,236
Property Additions	0	0	0	0
Interest Expense	0	0	0	0
Depreciation	0	0	0	0
Consulting [Member]
Revenue	298,162	349,131	422,057	603,238
Segment Profit - Pre Tax	(228,641)	2,131	(289,559)	83,040
Total Assets	247,144	408,231	247,144	408,231
Property Additions	0	0	0	0
Interest Expense	0	0	0	0
Depreciation	0	0	0	0
Technology [Member]
Revenue	0	0	0	0
Segment Profit - Pre Tax	(394,715)	(624,448)	(607,545)	(1,056,535)
Total Assets	883,775	764,714	883,775	764,714
Property Additions	0	0	0	0
Interest Expense	0	0	0	0
Depreciation	0	0	0	0
Corporate and Eliminations [Member]
Revenue		0	0	0
Segment Profit - Pre Tax	(858,265)	(1,032,791)	(1,663,489)	(2,115,535)
Total Assets	2,900,566	1,899,181	2,900,566	1,899,181
Property Additions	0	0	0	0
Interest Expense	0	0	0	0
Depreciation	$ 0	$ 0	$ 0	$ 0